Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Arthritis Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Arthritis Other
    Canakinumab Approved in EU for Patients 4 Years and Older With Cryopyrin-Associated Periodic Syndromes - (DGNews)
    Canakinumab Gives Faster, Greater Pain Relief in Refractory Gout Patients: Presented at ACR/ARHP - (DGDispatch)
    Previous Urate-Lowering Therapy Plus Febuxostat Lowers Urate Levels, Number of Flares in Patients With Gout: Presented at ACR/ARHP - (DGDispatch)
    Canakinumab Therapy Shows Promise for Systemic Juvenile Idiopathic Arthritis: Presented at AAP - (DGDispatch)
    New Interleukin-12/23 Monoclonal Antibody Effective Against Moderate to Severe Psoriasis: Presented at EADV - (DGDispatch)

    News archive

     Recent webcasts/CME - Arthritis Other
      Molecular Mechanism of Cardiovascular Disease in Inflammatory Arthritis
      Getting to the Root of Gout and Hyperuricemia: Core Principles in Diagnosis and Management for Rheumatologists
      Ankylosing Spondylitis
      Psoriatic Arthritis
      The Epidemiology of Increased Cardiovascular Death in Inflammatory Arthritis

      Webcasts/CME archive

       Recent cases - Arthritis Other
        Papular Xanthomas and Erosive Arthritis in a 3 Year Old Girl, is This a New MRH Variant?
        Idiopathic Destructive Arthritis of the Shoulder
        Superior Dislocation of the Patella: A Case Report
        Concurrent Reactive Arthritis and Myelitis - A Case Report
        Infectious Arthritis of the Knee Caused by Mycobacterium Terrae: A Case Report

        Cases archive
          




        my personal edition > arthritis other > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Juvenile Arthritis Classification Criteria Compared In Nordic Study

        A DGReview of :"Construct Validity of ILAR and EULAR Criteria in Juvenile Idiopathic Arthritis: A Population Based Incidence Study from the Nordic Countries"
        Journal of Rheumatology

        12/14/2001
        By Anne MacLennan


        Comparison of the proposed new and older classification criteria for juvenile idiopathic arthritis is complicated by the differing operational definitions they use of the subvariables.

        Using the new ILAR rather than EULAR criteria, the number of cases with juvenile arthritis increases by 10 percent, considering the first half-year after onset.

        However, validity of the ILAR criteria is low; these criteria frequently exclude patients from subgroup classification, and the possibility of having more than one diagnosis is not negligible. Furthermore, specified exclusion criteria for some of the subgroups are difficult to fulfill in clinical work, and the variables involved are questionable in terms of their consistency.

        Construct validity of the two sets of criteria refers to how closely the two instruments are related and how each operates in classifying subgroups/categories.

        The proposed new criteria (ILAR) are more descriptive than those formerly used [American College of Rheumatology (ACR), European League Against Rheumatism (EULAR)] but require validation against classifications already in use. This research group validated the ILAR in relation to the EULAR criteria and analysed their feasibility.

        In the study, 20 doctors in five Nordic countries collected data from the incidence cases within their catchment areas over an 18-month period beginning July 1, 1997. Clinical and serological data from the first year of disease were collected. A total of 322 patients were included.

        Classification by the ILAR criteria was possible in 321 patients; 290 patients had a disease duration of three months or less and were classified according to the EULAR criteria. One child could only be classified according to the EULAR criteria.

        Thus, 31 of 322 children (9.6 percent) were classified according to the ILAR criteria only. Forty-eight of 321 patients (15 percent) did not fit any category, and 6 percent (20 of 321) fulfilled criteria for two categories.

        In the ILAR classification, five of seven categories/subgroups have two to five specified exclusion criteria that highly discriminate the definition of each patient.

        In this study, the exclusion criteria were fulfilled to only a small extent.

        Study author is Lillemor Berntson and colleagues for the Nordic Study Group following a population-based incidence study in the Nordic countries of the construct validity of the EULAR and ILAR criteria in juvenile idiopathic arthritis.
        J Rheumatol 2001;28:2737-43. "Construct Validity of ILAR and EULAR Criteria in Juvenile Idiopathic Arthritis: A Population Based Incidence Study from the Nordic Countries"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send